These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. In vivo stability, disposition and metabolism of a "hybrid" oligonucleotide phosphorothioate in rats. Zhang R; Lu Z; Zhao H; Zhang X; Diasio RB; Habus I; Jiang Z; Iyer RP; Yu D; Agrawal S Biochem Pharmacol; 1995 Aug; 50(4):545-56. PubMed ID: 7646561 [TBL] [Abstract][Full Text] [Related]
11. Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract. Hiratou T; Miyano-Kurosaki N; Tsukahara S; Tamura Y; Takai K; Yamamoto N; Takaku H Int J Mol Med; 2000 Feb; 5(2):125-32. PubMed ID: 10639589 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev. Lund OS; Nielsen JO; Hansen JE Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762 [TBL] [Abstract][Full Text] [Related]
13. Development of siRNA for therapeutics: efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS). Ravikumar VT; Andrade M; Carty RL; Dan A; Barone S Bioorg Med Chem Lett; 2006 May; 16(9):2513-7. PubMed ID: 16481168 [TBL] [Abstract][Full Text] [Related]
14. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. Kawasaki AM; Casper MD; Freier SM; Lesnik EA; Zounes MC; Cummins LL; Gonzalez C; Cook PD J Med Chem; 1993 Apr; 36(7):831-41. PubMed ID: 8464037 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues. Shinozuka K; Okamoto T; Matsukura M; Sawai H Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the stereocontrolled synthesis of antisense phosphorothioates. Lu Y Mini Rev Med Chem; 2006 Mar; 6(3):319-30. PubMed ID: 16515471 [TBL] [Abstract][Full Text] [Related]
18. The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos. Woolf TM; Jennings CG; Rebagliati M; Melton DA Nucleic Acids Res; 1990 Apr; 18(7):1763-9. PubMed ID: 1692405 [TBL] [Abstract][Full Text] [Related]
19. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells. Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters. Ravikumar VT; Kumar RK; Capaldi DC; Cole DL Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]